Zobrazeno 1 - 10
of 10
pro vyhledávání: '"L S Snegireva"'
Autor:
Mikhail Mikhailovich Kostik, L S Snegireva, M F Dubko, V V Masalova, T S Likhacheva, O V Kalashnikova, V G Chasnyk
Publikováno v:
Современная ревматология, Vol 7, Iss 3, Pp 14-20 (2013)
Autoinflammatory syndromes (AISs) are a group of predominantly hereditary diseases associated with the spontaneous uncontrolled production of proinflammatory cytokines. Most diseases are known to have molecular mechanisms and an inheritance pattern.
Externí odkaz:
https://doaj.org/article/9f95a68a8cc145f089c29f350e15c797
Autor:
L. S. Sorokina, I. S. Avrusin, R. K. Raupov, N. T. Garipova, M. M. Gharabaghtsyan, S. V. Khrypov, M. A. Kaneva, E. A. Isupova, E. V. Gaidar, I. A. Chikova, M. F. Dubko, V. V. Masalova, T. S. Likhacheva, L. S. Snegireva, O. V. Kalashnikova, M. M. Kostik
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 1, Pp 102-111 (2022)
Systemic corticosteroids are continued to be administered in juvenile idiopathic arthritis (JIA) patients, especially in systemic JIA (sJIA), despite the ability of biologic therapy. One of the complications of long-term CS treatment is delayed hip a
Externí odkaz:
https://doaj.org/article/46434a680c7e46e1b670db62844d2c60
Autor:
E. M. Kalashnikova, R. K. Raupov, N. A. Lyubimova, E. M. Kuchinskaya, V. V. Masalova, E. A. Isupova, E. V. Gaidar, M. F. Dubko, L. S. Snegireva, L. S. Sorokina, T. L. Kornishina, M. A. Kaneva, I. A. Chikova, T. S. Likhacheva, O. L. Kolobova, O. V. Kalashnikova, V. G. Chasnyk, M. M. Kostik
Publikováno v:
Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 68:74-84
Systemic lupus erythematosus is an immunopathological disease which is characterized by a poor prognosis. Biologics applied in the disease treatment allow reducing the corticosteroid toxicity and controlling the disease.Purpose. To evaluate the effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::843dd991e9eb07d415bc1a8d60906560
https://doi.org/10.21508/1027-4065-2023-68-1-74-84
https://doi.org/10.21508/1027-4065-2023-68-1-74-84
Autor:
E. V. Gaidar, M. M. Kostik, M. F. Dubko, V. V. Masalova, L. S. Snegireva, E. A. Isupova, T. N. Nikitina, E. D. Serogodskaya, O. V. Kalashnikova, V. G. Chasnyk
Publikováno v:
Педиатрическая фармакология, Vol 13, Iss 4, Pp 340-344 (2016)
Background: Juvenile idiopathic arthritis (JIA) associated uveitis may be the cause of not only visual acuity decrement, but also blindness. At the same time, in some patients therapy with methotrexate can not prevent the development of these complic
Externí odkaz:
https://doaj.org/article/f97cc0bd41274ac085ce2ba372bf2e82
Autor:
M. M. Kostik, E. V. Gaydar, M. F. Dubko, V. V. Masalova, L. S. Snegireva, I. A. Chikova, E. A. Isupova, T. N. Nikitina, E. D. Serogodskaya, O. V. Kalashnikova, A. Ravelli, V. G. Chasnyk
Publikováno v:
Вопросы современной педиатрии, Vol 14, Iss 4, Pp 477-482 (2015)
Background: Uveitis is one of the most common extra-articular manifestations of juvenile idiopathic arthritis (JIA). Currently, the possibility of reducing the risk of uveitis in children with JIA by using methotrexate has been studied.Objective: Our
Externí odkaz:
https://doaj.org/article/9bc2729b6f294ef38331519246db5ed7
Autor:
M. M. Kostik, M. F. Dubko, L. S. Snegireva, V. V. Masalova, T. L. Kornishina, T. S. Likhacheva, I. A. Chikova, E. A. Isupova, E. M. Kuchinskaya, N. I. Glebova, O. V. Kalashnikova, V. G. Chasnykh
Publikováno v:
Вопросы современной педиатрии, Vol 12, Iss 5, Pp 18-23 (2013)
Aim: to perform retrospective evaluation of tocilizumab (TCZ) treatment every 2 and 4 weeks. Patients and methods: 33 children with systemic juvenile idiopathic arthritis (sJIA) were observed. Results: children, who need TCZ treatment every 2 weeks h
Externí odkaz:
https://doaj.org/article/38b644be909b44d6ab4d49f702470992
Autor:
O. P. Kozlova, M. M. Kostik, M. D. Kuznetsova, M. F. Dubko, L. S. Snegireva, A. L. Shavkin, E. A. Ligostaeva, O. L. Kopchak, S. M. Ignatieva, T. S. Bogomolova, N. N. Klimko
Publikováno v:
Žurnal Infektologii, Vol 12, Iss 5, Pp 48-55 (2021)
Introduction. In children with rheumatic diseases, severe fungal infections (invasive mycoses – IM) are not well understood.Objectives. To analyze risk factors, disease course of IM in children with systemic rheumatic diseases.Materials and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe99de54c27dc59c6e502a3a4227aa94
https://doi.org/10.22625/2072-6732-2020-12-5-48-55
https://doi.org/10.22625/2072-6732-2020-12-5-48-55
Autor:
M. M. Kostik, E. A. Isupova, I. A. Chikova, M. F. Dubko, V. V. Masalova, L. S. Snegireva, O. V. Kalashnikova, V. G. Chasnyk
Publikováno v:
Современная ревматология, Vol 11, Iss 4, Pp 30-39 (2018)
Objective: to study the efficiency and safety of tocilizumab (TCZ) therapy in patients with systemic-onset juvenile idiopathic arthritis (sJIA). Patients and methods. The retrospective study included 48 children with active sJIA in whom TCZ therapy w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a59ae0488da1be31b9c10fc603c09fb9
https://mrj.ima-press.net/mrj/article/view/793
https://mrj.ima-press.net/mrj/article/view/793
Autor:
N. A. Lyubimova, L. S. Snegireva, N. A. Terentyev, R. V. Idrisova, V. V. Avramenko, A. I. Imelbaev, O. L. Krasnogorskaya, M. M. Kostik
Publikováno v:
Современная ревматология, Vol 11, Iss 4, Pp 40-47 (2018)
The paper gives the data available in the literature on the relatively rare disease hypertrophic osteoarthropathy (HOA). This syndrome includes symptoms, such as clubbed fingers (hypertrophy of the distal phalanges), periostosis (subperiosteal new bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19869f29a3ec24983d405798994be727
https://mrj.ima-press.net/mrj/article/view/794
https://mrj.ima-press.net/mrj/article/view/794
Autor:
M. M. Kostik, M. F. Dubko, V. V. Masalova, L. S. Snegireva, I. A. Chikova, E. A. Isupova, O. V. Kalashnikova, V. G. Chasnyk
Publikováno v:
Современная ревматология, Vol 9, Iss 1, Pp 55-59 (2015)
Macrophage activation syndrome (MAS) is a severe life-threatening complication presenting with hemophagocytosis, pancytopenia, coagulopathy, and liver and CNS dysfunctions. The disease belongs to a group of histiocytic disorders. The common triggers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bdfe02e8629b3258fdb41fbd3a62d44
https://doi.org/10.14412/1996-7012-2015-1-55-59
https://doi.org/10.14412/1996-7012-2015-1-55-59